MetLife (MET) Earnings Analysis

MetLife (MET) has no confirmed upcoming earnings date. Last quarter (2026-02-04) it beat with EPS 2.58 USD vs 2.34 USD est (+10.3%). It has beaten estimates in 2/4 recent quarters (50%). Trailing P/E 17.97.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does MET next report earnings?

No confirmed upcoming earnings date is currently scheduled for MET. This page updates as the calendar is published.

MET earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-042.58 USD2.34 USD+10.3%Beat
2025-04-301.96 USD2 USD-2%Miss
2025-02-052.08 USD2.11 USD-1.4%Miss
2024-07-312.28 USD2.1 USD+8.6%Beat

Beat rate: 2/4 (50%) over reported quarters with consensus data.

MET valuation and analyst view

Trailing P/E17.97
Trailing EPS5.551 USD
Price / book2.23
Dividend yield2.46%
Market cap60.06B
Analyst consensusBuy (25 buy / 8 hold / 0 sell)
Avg price target96.36 USD

Related research pages

Frequently asked questions

When is MetLife (MET)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for MET. This page updates as the calendar is published.

Did MET beat earnings last quarter?

In its 2026-02-04 report, MET posted EPS of 2.58 USD versus a 2.34 USD estimate — a beat of 10.3%.

What is MET's earnings track record?

Over the last 4 reported quarters with consensus data, MET beat estimates 2 times (50%).

What is MET's current P/E ratio and EPS?

MET trades at a trailing P/E of 17.97 on trailing EPS of 5.550613496932515 USD.

What do analysts rate MET?

Analyst consensus is "Buy" across 33 ratings (0 strong buy, 25 buy, 8 hold, 0 sell, 0 strong sell). Average 12-month price target: 96.36 USD.